Cyclopentane-1,3-diol → HCID 178451993, compound

HRID 2410373Notes

Reaction equation

HRID 2410373 reaction equation
[OH:1][C:2]1[C:7]2[C:8]([O:11][CH2:12][CH:13]3[CH2:18][CH2:17][N:16]([C:19]([O:21][C:22]([CH3:25])([CH3:24])[CH3:23])=[O:20])[CH2:15][CH2:14]3)=[N:9][O:10][C:6]=2[CH:5]=[CH:4][CH:3]=1.[CH:26]1(O)[CH2:30][CH:29]([OH:31])[CH2:28][CH2:27]1.O[CH2:34]CC1CCN(C(OC(C)(C)C)=O)CC1>>[OH:31][C@H:29]1[CH2:28][CH2:27][C@H:34]([O:1][C:2]2[C:7]3[C:8]([O:11][CH2:12][CH:13]4[CH2:14][CH2:15][N:16]([C:19]([O:21][C:22]([CH3:25])([CH3:24])[CH3:23])=[O:20])[CH2:17][CH2:18]4)=[N:9][O:10][C:6]=3[CH:5]=[CH:4][CH:3]=2)[CH2:26][CH2:30]1

Participants

4

Procedure

The title compound was prepared according to the procedure described in Step 2 of EXAMPLE 7 using tert-butyl 4-{[(4-hydroxy-1,2-benzisoxazol-3-yl)oxy]methyl}piperidine-1-carboxylate (EXAMPLE 17, step 2) and 1,4-cyclopentanediol (mixture of isomers, cis: trans=ca. 1:1) instead of 4-(benzyloxy)-1,2-benzisoxazol-3-ol and tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate.

Sources & evidence

ORD record
ord-e9434dba87b24f448411dc159e0daafb
Source dataset
uspto-grants-2014_08
Patent number
US08816090B2

Reaction notes

Loading…